Investigator-initiated trial of crofelemer for congenital diarrheal disorders (CDDs) in children.
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
Price : $35 *
At a glance
- Drugs Crofelemer (Primary)
- Indications Congenital disorders; Diarrhoea
- Focus Therapeutic Use
- 29 Jan 2018 New trial record
- 22 Jan 2018 According to a Jaguar Health media release, Napo has accepted a request for support submitted by Dr. Mohamad Miqdady, Chief of Pediatric Gastroenterology, Hepatology and Nutrition at Sheikh Khalifa Medical City (SKMC) in Abu Dhabi, for this trial.